Advisory Committee on Organ Transplantation Notice of Meeting, 1643-1644 [2015-00322]

Download as PDF 1643 Federal Register / Vol. 80, No. 8 / Tuesday, January 13, 2015 / Notices FDA estimates the burden of this collection of information as follows: TABLE 2—ESTIMATED ANNUAL REPORTING BURDEN 1 Disclosure regarding additional risks in DTC prescription drug TV ads Pilot Study Screener .......... Number of responses per respondent Number of respondents Pilot Study .......................... 1700 (insomnia), 539 (high cholesterol), 3774 (depression). 4252 (insomnia), 1347 (high cholesterol), 9433 (depression). 600 (200 for each medical condition) ................... Main Study ......................... Total ............................ Main Study Screener .......... 1 There 1 6,013 1 15,032 1 600 1500 (500 for each medical condition) ................. 1 1500 ........................................................................... ........................ ........................ Average burden per response Total hours 0.03 (2 minutes). 0.03 (2 minutes). 0.50 (30 minutes). 0.50 (30 minutes). 180 ................ 1,681 451 300 750 are no capital costs or operating and maintenance costs associated with this collection of information. Dated: January 7, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–00269 Filed 1–12–15; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Committee on Organ Transplantation Notice of Meeting asabaliauskas on DSK5VPTVN1PROD with NOTICES Total annual responses In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Committee on Organ Transplantation (ACOT). Date And Time: January 27, 2015, from 12:30 p.m. to 4:30 p.m. Eastern Standard Time. Place: The meeting will be via audio conference call and Adobe Connect Pro. Status: The meeting will be open to the public. Purpose: Under the authority of 42 U.S.C. Section 217a, Section 222 of the Public Health Service Act, as amended, and 42 CFR 121.12 (2000), ACOT was established to assist the Secretary in enhancing organ donation, ensuring that the system of organ transplantation is grounded in the best available medical science, and assuring the public that the system is as effective and equitable as possible, thereby increasing public confidence in the integrity and effectiveness of the transplantation system. ACOT is composed of up to 25 members including the Chair. Members serve as Special Government Employees and have diverse backgrounds in fields such as organ donation, health care public policy, transplantation medicine and surgery, critical care medicine, and VerDate Sep<11>2014 17:10 Jan 12, 2015 Jkt 235001 other medical specialties involved in the identification and referral of donors, non-physician transplant professions, nursing, epidemiology, immunology, law and bioethics, behavioral sciences, economics and statistics, as well as representatives of transplant candidates, transplant recipients, organ donors, and family members. Agenda: The Committee will hear presentations including those on the following topics: Kidney Paired Donation, Vascularized Composite Allografts; the HOPE Act; and recommendations sent to the Secretary. Agenda items are subject to change as priorities indicate. After Committee discussions, members of the public will have an opportunity to comment. Because of the Committee’s full agenda and timeframe in which to cover the agenda topics, public comment will be limited. All public comments will be included in the record of the ACOT meeting. Meeting summary notes will be posted on Department’s organ donation Web site at https://www.organdonor.gov/ legislation/advisory.html#meetings. The draft meeting agenda will be posted on www.blsmeetings.net/ACOT. Those participating in this meeting should register by visiting www.blsmeetings.net/ACOT. The deadline to register for this meeting is Monday, January 26, 2015. For all logistical questions and concerns, please contact Anita Allen, Seamon Corporation at 301–658–3442 or send an email to aallen@seamoncorporation.com. The public can join the meeting by: 1. (Audio Portion) Calling the Conference Phone Number (888–324– 4391) and providing the Participant Code (2426); and 2. (Visual Portion) Connecting to the ACOT Adobe Connect Pro Meeting PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 using the following URL and entering as GUEST: https://hrsa.connectsolutions.com/ acot1/ (copy and paste the link into your browser if it does not work directly, and enter as a guest). Participants should call and connect 15 minutes prior to the meeting for logistics to be set up. If you have never attended an Adobe Connect meeting, please test your connection using the following URL: https://hrsa.connect solutions.com/common/help/en/ support/meeting_test.htm and get a quick overview by following URL: https://www.adobe.com/go/connectpro_ overview. Call (301) 443–0437 or send an email to ptongele@hrsa.gov if you are having trouble connecting to the meeting site. Public Comment: It is preferred that persons interested in providing an oral presentation email a written request, along with a copy of their presentation, to Patricia Stroup, MBA, MPA, Executive Secretary, Healthcare Systems Bureau, Health Resources and Services Administration, at pstroup@hrsa.gov. Requests should contain the name, address, telephone number, email address, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may request it during the public comment period. Public participation and ability to comment will be limited to time as it permits. FOR FURTHER INFORMATION CONTACT: Patricia Stroup, MBA, MPA, Executive E:\FR\FM\13JAN1.SGM 13JAN1 1644 Federal Register / Vol. 80, No. 8 / Tuesday, January 13, 2015 / Notices Secretary, Healthcare Systems Bureau, Health Resources and Services Administration, 5600 Fishers Lane, Room 17W65, Rockville, Maryland 20857; telephone (301) 443–1127. Jackie Painter, Acting Director, Division of Policy and Information Coordination. [FR Doc. 2015–00322 Filed 1–12–15; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Library of Medicine; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. asabaliauskas on DSK5VPTVN1PROD with NOTICES Name of Committee: National Library of Medicine Special Emphasis Panel; Conflicts R01. Date: March 6, 2015. Time: 12:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Library of Medicine, 6705 Rockledge Drive, Suite 301, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Zoe E. Huang, MD, Scientific Review Officer, Extramural Programs, National Library of Medicine, NIH, 6705 Rockledge Drive, Suite 301, Bethesda, MD 20892–7968, 301–594–4937, huangz@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.879, Medical Library Assistance, National Institutes of Health, HHS) Dated: January 7, 2015. Michelle Trout, Program Analyst, Office of the Federal Advisory Committee Policy. [FR Doc. 2015–00280 Filed 1–12–15; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 17:10 Jan 12, 2015 Jkt 235001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; K-awards and R13 conference support review. Date: February 25, 2015. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, DEM II, Suite 920, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Manana Sukhareva, Ph.D., Scientific Review Officer, 6707 Democracy Boulevard, Suite 959, Bethesda, MD 20892, 301–451–3397, sukharem@mail.nih.gov. Dated: January 7, 2015. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–00289 Filed 1–12–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Peer Review Meeting. Date: February 2, 2015. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Room 3E61, 5601 Fishers Lane, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Raymond R. Schleef, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/ NIAID, 5601 Fishers Lane, Rockville, MD 20852–7616, 240–669–5019, schleefrr@ niaid.nih.gov. Late notification due to delayed response from panel members. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: January 7, 2015. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–00292 Filed 1–12–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Osteoporosis Fellowship Review. Date: January 20, 2015. Time: 4:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). E:\FR\FM\13JAN1.SGM 13JAN1

Agencies

[Federal Register Volume 80, Number 8 (Tuesday, January 13, 2015)]
[Notices]
[Pages 1643-1644]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-00322]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Committee on Organ Transplantation Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:
    Name: Advisory Committee on Organ Transplantation (ACOT).
    Date And Time: January 27, 2015, from 12:30 p.m. to 4:30 p.m. 
Eastern Standard Time.
    Place: The meeting will be via audio conference call and Adobe 
Connect Pro.
    Status: The meeting will be open to the public.
    Purpose: Under the authority of 42 U.S.C. Section 217a, Section 222 
of the Public Health Service Act, as amended, and 42 CFR 121.12 (2000), 
ACOT was established to assist the Secretary in enhancing organ 
donation, ensuring that the system of organ transplantation is grounded 
in the best available medical science, and assuring the public that the 
system is as effective and equitable as possible, thereby increasing 
public confidence in the integrity and effectiveness of the 
transplantation system. ACOT is composed of up to 25 members including 
the Chair. Members serve as Special Government Employees and have 
diverse backgrounds in fields such as organ donation, health care 
public policy, transplantation medicine and surgery, critical care 
medicine, and other medical specialties involved in the identification 
and referral of donors, non-physician transplant professions, nursing, 
epidemiology, immunology, law and bioethics, behavioral sciences, 
economics and statistics, as well as representatives of transplant 
candidates, transplant recipients, organ donors, and family members.
    Agenda: The Committee will hear presentations including those on 
the following topics: Kidney Paired Donation, Vascularized Composite 
Allografts; the HOPE Act; and recommendations sent to the Secretary. 
Agenda items are subject to change as priorities indicate.
    After Committee discussions, members of the public will have an 
opportunity to comment. Because of the Committee's full agenda and 
timeframe in which to cover the agenda topics, public comment will be 
limited. All public comments will be included in the record of the ACOT 
meeting. Meeting summary notes will be posted on Department's organ 
donation Web site at https://www.organdonor.gov/legislation/advisory.html#meetings.
    The draft meeting agenda will be posted on www.blsmeetings.net/ACOT. Those participating in this meeting should register by visiting 
www.blsmeetings.net/ACOT. The deadline to register for this meeting is 
Monday, January 26, 2015. For all logistical questions and concerns, 
please contact Anita Allen, Seamon Corporation at 301-658-3442 or send 
an email to aallen@seamoncorporation.com.
    The public can join the meeting by:
    1. (Audio Portion) Calling the Conference Phone Number (888-324-
4391) and providing the Participant Code (2426); and
    2. (Visual Portion) Connecting to the ACOT Adobe Connect Pro 
Meeting using the following URL and entering as GUEST:
https://hrsa.connectsolutions.com/acot1/ (copy and paste the link into 
your browser if it does not work directly, and enter as a guest). 
Participants should call and connect 15 minutes prior to the meeting 
for logistics to be set up. If you have never attended an Adobe Connect 
meeting, please test your connection using the following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and 
get a quick overview by following URL: https://www.adobe.com/go/connectpro_overview. Call (301) 443-0437 or send an email to 
ptongele@hrsa.gov if you are having trouble connecting to the meeting 
site.
    Public Comment: It is preferred that persons interested in 
providing an oral presentation email a written request, along with a 
copy of their presentation, to Patricia Stroup, MBA, MPA, Executive 
Secretary, Healthcare Systems Bureau, Health Resources and Services 
Administration, at pstroup@hrsa.gov. Requests should contain the name, 
address, telephone number, email address, and any business or 
professional affiliation of the person desiring to make an oral 
presentation. Groups having similar interests are requested to combine 
their comments and present them through a single representative.
    The allocation of time may be adjusted to accommodate the level of 
expressed interest. Persons who do not file an advance request for a 
presentation, but desire to make an oral statement, may request it 
during the public comment period. Public participation and ability to 
comment will be limited to time as it permits.

FOR FURTHER INFORMATION CONTACT:  Patricia Stroup, MBA, MPA, Executive

[[Page 1644]]

Secretary, Healthcare Systems Bureau, Health Resources and Services 
Administration, 5600 Fishers Lane, Room 17W65, Rockville, Maryland 
20857; telephone (301) 443-1127.

Jackie Painter,
Acting Director, Division of Policy and Information Coordination.
[FR Doc. 2015-00322 Filed 1-12-15; 8:45 am]
BILLING CODE 4165-15-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.